RECRUITING

Intensive Speech Motor Chaining Treatment for Residual Speech Sound Disorders

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this randomized-controlled trial is to compare distributed treatment schedules and intensive treatment schedules in 84 school-age children with residual speech sound disorders. The main question it aims to answer is: * How does intensive and distributed treatment affect speech sound learning in residual speech sound disorder? Some participants will be treated with a traditional Distributed schedule of 2 sessions per weeks for 8 weeks (16 hours total), whereas others will be treated with an Intensive schedule and will complete 16 hours of treatment in 4 weeks.

Official Title

Intensive Speech Motor Chaining Treatment for Residual Speech Sound Disorders

Quick Facts

Study Start:2023-10-26
Study Completion:2027-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05929859

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:9 Years to 17 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD
Inclusion CriteriaExclusion Criteria
  1. * Must speak American English as a dominant language.
  2. * Must have began learning English by at least the age of 3 years.
  3. * Must be between 9;0 to 17;11 years of age.
  4. * Must have reported difficulty with /ɹ/ and/or /s/ production
  5. * Must pass pure tone hearing screening at 25 dB at 1000, 2000, and 4000 Hz.
  6. * Must receive a scaled score of at least 5 on the Listening Comprehension and Story Retelling subtests of the Test of Integrated Language and Literacy Skills (TILLS)
  7. * Must receive a percentile score of 5 or below on the Goldman-Fristoe Test of Articulation-3 (GFTA-3) Sounds in Words subtest.
  8. * Must have 1 scorable response with 5+ consecutive correct /pataka/ with \> 3.4 syllables per second in the MRR-Tri task of the Maximum Performance Tasks OR must demonstrate no childhood apraxia of speech (CAS-only) features in BOTH articulatory and rate/prosody domains of the ProCAD.
  9. * Must score \<40% accurate on /ɹ/ and/or /s/ probes assessing these sounds at the word level.
  10. * Must express a desire to modify their speech.
  1. * Must have no known history of autism spectrum disorder, Down Syndrome, cerebral palsy, intellectual disability, permanent hearing loss, or brain injury.
  2. * Must not have current cleft palate or voice disorder.

Contacts and Locations

Study Contact

Jonathan Preston, PhD
CONTACT
315-443-1351
jopresto@syr.edu
Nina Benway, PhD
CONTACT
nrbenway@syr.edu

Principal Investigator

Jonathan Preston, PhD
PRINCIPAL_INVESTIGATOR
Syracuse University

Study Locations (Sites)

Syracuse University
Syracuse, New York, 13244
United States

Collaborators and Investigators

Sponsor: Syracuse University

  • Jonathan Preston, PhD, PRINCIPAL_INVESTIGATOR, Syracuse University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-10-26
Study Completion Date2027-12

Study Record Updates

Study Start Date2023-10-26
Study Completion Date2027-12

Terms related to this study

Additional Relevant MeSH Terms

  • Speech Sound Disorder